Serum DHCR24 Auto-antibody as a new Biomarker for Progression of Hepatitis C

Serum DHCR24 Auto-antibody as a new Biomarker for Progression of Hepatitis C

Background: New biomarkers are needed to identify the stage of hepatitis C virus (HCV)-infected diseases in order to reduce the mortality rates. Herein, we investigated whether serum 3β-hydroxysterol Δ24-reductase antibody (DHCR24 Ab) may serve as a prognostic marker for hepatitis C infection progre...

Full description

Bibliographic Details
Main Authors: Sayeh Ezzikouri, Kiminori Kimura, Hajime Sunagozaka, Shuichi Kaneko, Kazuaki Inoue, Tomohiro Nishimura, Tsunekazu Hishima, Michinori Kohara, Kyoko Tsukiyama-Kohara
Format: Article
Language:English
Published: Elsevier 2015-06-01
Series:EBioMedicine
Subjects:
3β-Hydroxysterol Δ24-reductase antibody
Serum autoantibody
Liver cancer
Biomarker
Hepatitis C virus
Online Access:http://www.sciencedirect.com/science/article/pii/S2352396415001012

Internet

http://www.sciencedirect.com/science/article/pii/S2352396415001012

Similar Items